Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 25, 2017

DrugPatentWatch Database Preview

Chlorthalidone - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for chlorthalidone and what is the scope of chlorthalidone patent protection?

is the generic ingredient in nine branded drugs marketed by Watson Labs, Barr Labs Inc, Riconpharma Llc, Kv Pharm, Vangard, Warner Chilcott, Sandoz, Mylan, Mutual Pharm, Purepac Pharm, Ivax Pharms, Superpharm, Dava Pharms Inc, G And W Labs Inc, Usl Pharma, Monarch Pharms, Abbott, Casper Pharma Llc, Sanofi Aventis Us, Sun Pharm Inds, Pioneer Pharms, Ascot, Boehringer Ingelheim, Par Pharm, and Novartis, and is included in fifty-four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for chlorthalidone. Fifteen suppliers are listed for this compound.

Summary for Generic Name: chlorthalidone

Drug Master File Entries: see list15
Suppliers / Packagers: see list15
Bulk Api Vendors: see list55
Clinical Trials: see list24
Patent Applications: see list5,428
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:chlorthalidone at DailyMed

Pharmacology for Ingredient: chlorthalidone

Drug ClassThiazide-like Diuretic
Physiological EffectIncreased Diuresis
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
TABLET;ORAL087521-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Riconpharma Llc
TABLET;ORAL206904-002Mar 30, 2017ABRXNoNo► Subscribe► Subscribe
Usl Pharma
TABLET;ORAL089052-001Jun 1, 1987DISCNNoNo► Subscribe► Subscribe
TABLET;ORAL087380-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Sun Pharm Inds
TABLET;ORAL089286-002Jul 21, 1986ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Uncover prior art in abandoned patent applications and expired patents
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus